402 results on '"Fedi S"'
Search Results
52. CONTAMINATION DURING MICROPROPAGATION: ANALYSIS OF THE BACTERIAL LINES AND TREATMENT WITH SAGE EXTRACT
53. Thermophilic bio-hydrogen production from food industry waste in suspended- and attached-cell reactors: preliminary screening in 0.12-L bioreactors and scale-up to a 19-L pilot reactor
54. Chloroform aerobic cometabolism by butane-growing Rhodococcus aetherovorans BCP1 in continuous-flow biofilm reactors
55. Analyses of both the alkB Gene Transcriptional Start Site and alkB Promoter-Inducing Properties of Rhodococcus sp. Strain BCP1 Grown on n -Alkanes
56. Environmental impact of genetically modified Azospirillum brasilense, Pseudomonas fluorescens, and Rhizobium leguminosarum released as soil/seed inoculants
57. A histidine-kinasecheAgene ofPseudomonas pseudoalcaligensKF707 not only has a key role in chemotaxis but also affects biofilm formation and cell metabolism
58. Lower Homocysteine Levels in Renal Transplant Recipients Treated With Everolimus: A Possible Link With A Decreased Cardiovascular Risk?
59. Heparin-induced thrombocytopenia incidence in the ICU: preliminary results
60. [117] PROTEIN Z LEVELS AND VASCULAR THROMBOTIC DISEASES? A META-ANALYSIS
61. 118 PROTEIN Z DEPENDENT PROTEASE INHIBITOR (ZPI) AND PROTEIN Z IN PERIPHERAL ARTERIAL DISEASE PATIENTS
62. 119 INFLUENCE OF ALCOHOL BEVERAGES AND DRINKING PATTERN ON HOMOCYSTEINE CONCENTRATIONS
63. 121 LP(a): A POSSIBLE LINK WITH MIGRAINE
64. 117 THROMBOPHILIC AND RHEOLOGICAL PARAMETERS AS INDEPENDENT RISK FACTORS FOR RETINAL VEIN OCCLUSION
65. 58 THROMBOTIC EVENTS IN HIGH RISK PATIENTS ARE PREDICTED BY EVALUATING DIFFERENT PATHWAYS OF PLATELET FUNCTION
66. FISH INTAKE AND LPA 93CT POLYMORPHISM: GENE-ENVIRONMENT INTERACTION IN MODULATING LIPOPROTEIN (A) CONCENTRATIONS
67. High plasma homocysteine concentrations in cerebrovascular patients with Fabry disease
68. Mo-P2:177 Protein Z levels and prognosis in patients with acute coronary syndromes
69. Homocysteine plasma levels in primary biliary cirrhosis (PBC)
70. Protein Z levels in acute coronary syndromes
71. 7 P High prevalence of hypercoagulability state and elevated plasma levels of homocysteine in patients with primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC)
72. Thrombophilias as risk factors for disorders of pregnancy and fetal damage
73. OP0037 Fibrinolytic system and ace i/d polymorphism in systemic sclerosis
74. Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility
75. Effect of Tourniquet Use on Activation of Coagulation in Total Knee Replacement
76. Procedure-dependence and Tissue Factor-independence of Hypercoagulability during Orthopaedic Surgery
77. Tissue Factor Reduction and Tissue Factor Pathway Inhibitor Release after Heparin Administration
78. CHANGES IN LIPIDIC AND HEMOSTATIC PARAMETERS INDUCED BY TIBOLONE TREATMENT.
79. Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus
80. Changes in coagulation and fibrinolysis by antiandrogen drug (cyproterone acetate and flutamide) use
81. A versatile most probable number system to quantify lacZY-marked pseudomonads present at low cell numbers in the rhizosphere
82. Analyses of both the alkB Gene Transcriptional Start Site and alkB Promoter-Inducing Properties of Rhodococcus sp. Strain BCP1 Grown on n-Alkanes.
83. A histidine-kinase cheA gene of Pseudomonas pseudoalcaligens KF707 not only has a key role in chemotaxis but also affects biofilm formation and cell metabolism.
84. A proinflammatory state is associated with hyperhomocysteinemia in the elderly.
85. Dietary habits, lifestyle and cardiovascular risk factors in a clinically healthy Italian population: the‘Florence’diet is not Mediterranean.
86. Comparison of Some Serum Copper Parameters in Trained Runners and Control Subjects*
87. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test.
88. <span style="font-variant:small-caps">d</span> -Dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study
89. The role of cysteine and homocysteine in venous and arterial thrombotic disease.
90. Postprocedural PAI-1 Activity is a Risk Marker of Subsequent Clinical Restenosis in Patients Both with and without Stent Implantation After Elective Balloon PTCA
91. Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies
92. Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty
93. Effect of Temperature and Incubation Time on D-Dimer Serum Levels in Healthy Subjects
94. Electrophysiologic procedures and activation of the hemostatic system
95. Procedure-dependence and Tissue Factor-independence of Hypercoagulability during Orthopaedic Surgery
96. Protein Z levels, protein Z G79A polymorphism, and prothrombotic conditions.
97. Evaluation of Clotting and Fibrinolytic Activation after Protracted Physical Exercise
98. Blood clotting activation during normal pregnancy
99. Platelet and blood clotting activation in patients with mitral valve prolapse
100. Hemostatic abnormalities in inflammatory bowel disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.